HR 5333
115th Congress
House
Health
Administrative law and regulatory procedures
Drug safety, medical device, and laboratory regulation
Government studies and investigations
Inflation and prices
Prescription drugs
User charges and fees
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
Everywhere this bill has been
14 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 17, 2018
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 518.
Jul 16, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jul 16, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6227-6235)
Jul 16, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H6227-6235)
Jul 16, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5333.
Jul 16, 2018
Considered under suspension of the rules. (consideration: CR H6227-6237)
Jul 16, 2018
Mr. Latta moved to suspend the rules and pass the bill, as amended.
Jul 16, 2018
Placed on the Union Calendar, Calendar No. 640.
Jul 16, 2018
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-827.
May 9, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 9, 2018
Committee Consideration and Mark-up Session Held.
Mar 23, 2018
Referred to the Subcommittee on Health.
Mar 19, 2018
Referred to the House Committee on Energy and Commerce.
Mar 19, 2018
Introduced in House
Plain-English summary
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
This bill amends the Federal Food, Drug, and Cosmetic Act to substantially revise how over-the-counter (OTC) drugs are approved.
What's happening now
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 518.
Committees of jurisdiction
2